Related Experiment Video

Updated: Jul 16, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Cardiac amyloidosis - experience in a tertiary cardiac referral centre

Elaine M C Chau, Wing-Hing Chow, Elaine Wang

    International Journal of Cardiology
    |March 27, 2007
    PubMed

    Insights

    Cardiac amyloidosis, a rare heart condition, has a poor prognosis, with survival rates declining over time. Specific treatment for underlying amyloidosis significantly improves patient survival outcomes.

    Area of Science:

    • Cardiology
    • Nephrology
    • Oncology

    Background:

    • Amyloidosis is a rare systemic disease involving fibrillar protein deposition in organs.
    • Cardiac amyloidosis significantly worsens prognosis, often presenting late with limited treatment options.

    Discussion:

    • This study reports the largest series of 16 Chinese patients with cardiac amyloidosis.
    • Survival rates at 1, 3, and 5 years were 40%, 25%, and 17%, respectively.
    • Cardiac-related issues were the primary cause of mortality.

    Key Insights:

    • Patients with overt heart failure or untreated amyloidosis had a dismal prognosis (2.2 and 3.5 months survival).
    • Specific treatment for the underlying cause of amyloidosis led to improved outcomes, with an average survival of 33.4 months.

    Outlook:

    • Further research is needed to improve early diagnosis and effective treatment strategies for cardiac amyloidosis.
    • Developing targeted therapies for amyloidosis can potentially enhance long-term survival and quality of life for affected individuals.

    More Related Videos

    Transthoracic Echocardiographic Examination in the Rabbit Model14:46

    Transthoracic Echocardiographic Examination in the Rabbit Model

    Published on: June 1, 2019

    Related Concept Videos

    Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

    Cardiomyopathy III: Hypertrophic Cardiomyopathy

    Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
    Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

    Cardiomyopathy IV: Restrictive Cardiomyopathy

    Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
    Cardiomyopathy V: Interprofessional Care01:29

    Cardiomyopathy V: Interprofessional Care

    Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
    Cardiomyopathy II: Dilated Cardiomyopathy01:30

    Cardiomyopathy II: Dilated Cardiomyopathy

    Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
    Cardiomyopathy I: Introduction and Classification01:25

    Cardiomyopathy I: Introduction and Classification

    Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
    Acute Coronary Syndrome III: Diagnostic Studies01:30

    Acute Coronary Syndrome III: Diagnostic Studies

    Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...